Kyong H. Park
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 137 publications
Prediction of germline BRCA mutation using clinicopathologic, MRI semantic, and radiomics features in high-risk breast cancer patients: a multicenter study.
Journal: Frontiers in radiology
Published: April 17, 2026
A randomized phase III trial of anthracyclines followed by taxane versus taxane plus carboplatin as (neo)adjuvant therapy in patients with triple-negative breast cancer: KCSG BR 15-1 PEARLY trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 08, 2026
Amplification-Free and Label-Free Multiplexed Profiling of Extracellular Vesicle-Derived MicroRNA via Micropore Sensing Based on PNA-Functionalized Hydrogel Barcodes.
Journal: ACS sensors
Published: January 28, 2026
Integrative Genomic Analysis Reveals Molecular and Clinical Disparities between Bladder and Upper Tract Urothelial Carcinoma in K-MASTER Program.
Journal: Cancer research and treatment
Published: January 22, 2026
Functional characterization of BRCA2 variants of uncertain significance identified in Korean breast cancer patients.
Journal: Breast cancer (Tokyo, Japan)
Published: January 16, 2026
The clinical value of clinical treatment score post-5 years in patients with premenopausal breast cancer: a retrospective analysis of ASTRRA trial.
Journal: Breast (Edinburgh, Scotland)
Published: December 10, 2025
Correction: Comparative study on bone mineral density in premenopausal patients with estrogen receptor-positive breast cancer in ASTRRA Study: a 5-year follow-up study.
Journal: Frontiers in oncology
Published: October 21, 2025
Phase II study of trastuzumab-pkrb plus gedatolisib in patients with HER2-positive metastatic breast cancer who progressed after two or more HER2-directed therapies.
Journal: ESMO open
Published: October 13, 2025
Safety Evaluation of SH003 and Docetaxel Combination in Patients With Breast and Lung Cancer: A Multi-Center, Open-Label, Dose Escalation Phase I Clinical Trial.
Journal: Integrative cancer therapies
Published: August 09, 2025
Comparative immunohistochemical expression of TROP2 in brain metastatic and primary tumors.
Journal: American journal of cancer research
Published: August 08, 2025
Last Updated: 09/26/2026